2026年4月24日 美国东部时间10:57 / 福克斯新闻
男孩的母亲表示，儿子在接受再生元公司的治疗后现已恢复听力
作者：亚历克斯·尼茨伯格 福克斯新闻
周四在白宫的一场活动中，一位母亲分享了她原本失聪的儿子如今重获听力的故事。
全新功能：您现在可以收听福克斯新闻的文章了！
收听本文
时长：2分钟
周四在白宫的一场活动中，美国总统唐纳德·特朗普重点介绍了一名2岁男孩特拉维斯·史密斯。这名男孩生来失聪，但在接受了“奇迹疗法”后现已恢复听力。
“他现在能听到妈妈塞拉对他说‘我爱你’了，”总统说道，并邀请男孩的母亲上台发言。
“再生元创造了奇迹，”这位女士在谈及研发该疗法的公司时说道。
2026年4月23日，在华盛顿特区白宫椭圆形办公室举行的推进医疗负担能力活动上，两岁的特拉维斯·史密斯和母亲塞拉与美国总统唐纳德·特朗普一同出席活动时的反应。（亚历克斯·黄/盖蒂图片社）
“他以前不知道自己的名字，听不到我告诉他我有多爱他。而现在有了再生元的这项神奇手术，他能听音乐了。他非常喜欢，还喜欢跟着跳舞，”她说。
该公司在一份声明中表示，美国食品药品监督管理局已加速批准再生元的Otarmeni基因疗法产品。
2026年4月23日，在华盛顿特区白宫椭圆形办公室举行的推进医疗负担能力活动上，美国总统唐纳德·特朗普发表讲话。（威尔·奥利弗/美联社/彭博社 via 盖蒂图片社）
该公司透露，这款疗法将在美国免费提供。
“再生元将为美国境内符合临床条件的患者免费提供Otarmeni。这并不一定涵盖该免费疗法的给药相关自付费用，这部分费用不在再生元的控制范围内；患者应咨询其医疗保健提供商和/或保险公司，”该公司表示。
据该公司介绍，该疗法的给药方式需要通过手术。
“用于给药Otarmeni的手术过程与人工耳蜗植入类似，可用于年幼的婴儿，”声明中写道。“Otarmeni应由具备耳蜗内手术经验且接受过Otarmeni给药流程培训的外科医生实施，且仅可使用配套提供的Otarmeni给药套件进行给药。”
2026年4月23日，在华盛顿特区白宫椭圆形办公室举行的推进医疗负担能力活动上，再生元制药公司首席执行官伦纳德·施莱弗（中）发言，再生元制药公司总裁兼首席科学官乔治·扬科普洛斯在一旁观看。（亚历克斯·黄/盖蒂图片社）
点击此处下载福克斯新闻应用程序
特朗普在白宫活动中指出，再生元已“同意以最惠国待遇的大幅折扣价格提供其处方药”。
“通过这一公告，代表着品牌药市场80%份额的全球17家最大制药公司现已同意以全球最低价格向美国患者销售其药品，”他说道。
亚历克斯·尼茨伯格是福克斯新闻数字频道的撰稿人。
SEE IT: 2-year-old steals show at White House as Trump spotlights ‘miracle cure’ for deaf boy
April 24, 2026 10:57am EDT / Fox News
The boy’s mother says her son can now hear after undergoing Regeneron’s treatment
By Alex Nitzberg Fox News
During an event at the White House on Thursday, a mother spoke about how her son, who had been deaf, can now hear.
NEW You can now listen to Fox News articles!
Listen to this article
2 min
During an event at the White House on Thursday, President Donald Trump highlighted a 2-year-old boy, Travis Smith, who was born deaf but can now hear after taking a “miracle cure.”
The child can now “hear his mom, Sierra, say, ‘I love you,’” the president said, inviting the mother to speak.
“Regeneron works miracles,” the woman said, referring to the company behind the treatment.
Two-year-old Travis Smith and his mother Sierra react during an event with U.S. President Donald Trump on advancing health care affordability in the Oval Office of the White House on April 23, 2026, in Washington, D.C.(Alex Wong/Getty Images)
“He didn’t know his name. He couldn’t hear me tell him how much I love him. And now with Regeneron and this amazing surgery, he can listen to music. And he loves it. And he loves to dance,” she said.
The U.S. Food and Drug Administration has given accelerated approval for Regeneron’s Otarmeni gene therapy product, the company said in a statement.
President Donald Trump, center, speaks during a healthcare affordability event in the Oval Office of the White House in Washington, D.C., on Thursday, April 23, 2026.(Will Oliver/EPA/Bloomberg via Getty Images)
The company indicated that the treatment will be made available for free in the U.S.
“Regeneron will provide Otarmeni at no cost to clinically eligible individuals in the U.S. This may not necessarily reflect out-of-pocket costs for administration of this free therapy, which would be outside of the control of Regeneron; individuals should consult with their healthcare provider and/or insurance provider,” the company said.
Administering the treatment involves surgery, according to the company.
“The surgical procedure to administer Otarmeni uses an approach similar to cochlear implantation and allows use in young infants,” the statement said. “Otarmeni should be administered by a surgeon experienced in intracochlear surgery and trained in the Otarmeni administration process and should only be administered using the provided Administration Kit for use with Otarmeni.”
CEO of Regeneron Pharmaceuticals Leonard Schleifer, center, speaks as President and Chief Scientific Officer of Regeneron Pharmaceuticals George Yancopoulos looks on during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026, in Washington, D.C.(Alex Wong/Getty Images)
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Trump noted during the White House event that Regeneron has “agreed to offer their prescription medications at heavily discounted most favored nation prices.”
“With this announcement, 17 of the world’s largest pharmaceutical companies, representing 80% of the branded drug market, have now agreed to sell their drugs to American patients at the lowest prices anywhere in the world,” he said.
Alex Nitzberg is a writer for Fox News Digital.
发表回复